Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Middleton, RJ; Parfrey, PS; Foley, RN
   Left ventricular hypertrophy in the renal patient
   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
   
   R.J. Middleton et al., "Left ventricular hypertrophy in the renal patient", J AM S NEPH, 12(5), 2001, pp. 1079-1084
2. Parfrey, PS
   Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence, and risk
   AMERICAN JOURNAL OF KIDNEY DISEASES
   
   P.S. Parfrey, "Is renal insufficiency an atherogenic state? Reflections on prevalence, incidence, and risk", AM J KIDNEY, 37(1), 2001, pp. 154-156
3. Hutchinson, JM; Jelinski, S; Hefferton, D; Desaulniers, G; Parfrey, PS
   Role of diagnostic labeling in antibiotic prescription
   CANADIAN FAMILY PHYSICIAN
   
   J.M. Hutchinson et al., "Role of diagnostic labeling in antibiotic prescription", CAN FAM PHY, 47, 2001, pp. 1217-1224
4. Beales, PL; Katsanis, N; Lewis, RA; Ansley, SJ; Elcioglu, N; Raza, J; Woods, MO; Green, JS; Parfrey, PS; Davidson, WS; Lupski, JR
   Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohortreveal a minor involvement of BBS6 and delineate the critical intervals ofother loci
   AMERICAN JOURNAL OF HUMAN GENETICS
   
   P.L. Beales et al., "Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohortreveal a minor involvement of BBS6 and delineate the critical intervals ofother loci", AM J HU GEN, 68(3), 2001, pp. 606-616
5. Slavotinek, AM; Stone, EM; Mykytyn, K; Heckenlively, JR; Green, JS; Heon, E; Musarella, MA; Parfrey, PS; Sheffield, VC; Biesecker, LG
   Mutations in MKKS cause Bardet-Biedl syndrome
   NATURE GENETICS
   
   A.M. Slavotinek et al., "Mutations in MKKS cause Bardet-Biedl syndrome", NAT GENET, 26(1), 2000, pp. 15-16
6. Katsanis, N; Beales, PL; Woods, MO; Lewis, RA; Green, JS; Parfrey, PS; Ansley, SJ; Davidson, WS; Lupski, JR
   Mutations in MKKS cause obesity, retinal dystrophy and renal malformationsassociated with Bardet-Biedl syndrome
   NATURE GENETICS
   
   N. Katsanis et al., "Mutations in MKKS cause obesity, retinal dystrophy and renal malformationsassociated with Bardet-Biedl syndrome", NAT GENET, 26(1), 2000, pp. 67-70
7. Foley, RN; Parfrey, PS; Kent, GM; Harnett, JD; Murray, DC; Barre, PE
   Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease
   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
   
   R.N. Foley et al., "Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease", J AM S NEPH, 11(5), 2000, pp. 912-916
8. Murphy, SW; Barrett, BJ; Parfrey, PS
   Contrast nephropathy
   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
   
   S.W. Murphy et al., "Contrast nephropathy", J AM S NEPH, 11(1), 2000, pp. 177-182
9. Parfrey, PS
   Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   P.S. Parfrey, "Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management", NEPH DIAL T, 15, 2000, pp. 58-68
10. Bianchi, G; London, GM; Marcelli, D; Massy, ZA; Parfrey, PS; Passlick-Deetjen, J; Rabelink, TJ; Wanner, C
    Clinical algorithms on cardiovascular risk factors in renal patients
    NEPHROLOGY DIALYSIS TRANSPLANTATION
    
    G. Bianchi et al., "Clinical algorithms on cardiovascular risk factors in renal patients", NEPH DIAL T, 15, 2000, pp. 123
11. Rigatto, C; Parfrey, PS
    Homocysteine and cardiovascular risk in dialysis patients
    PERITONEAL DIALYSIS INTERNATIONAL
    
    C. Rigatto e P.S. Parfrey, "Homocysteine and cardiovascular risk in dialysis patients", PERIT DIA I, 20(2), 2000, pp. 167-168
12. Murphy, ST; Parfrey, PS
    The impact of anemia correction on cardiovascular disease in end-stage renal disease
    SEMINARS IN NEPHROLOGY
    
    S.T. Murphy e P.S. Parfrey, "The impact of anemia correction on cardiovascular disease in end-stage renal disease", SEM NEPHROL, 20(4), 2000, pp. 350-355
13. Foley, RN; Parfrey, PS; Morgan, J; Barre, PE; Campbell, P; Cartier, P; Coyle, D; Fine, A; Handa, P; Kingma, I; Lau, CY; Levin, A; Mendelssohn, D; Muirhead, N; Murphy, B; Plante, RK; Posen, G; Wells, GA
    Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
    KIDNEY INTERNATIONAL
    
    R.N. Foley et al., "Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy", KIDNEY INT, 58(3), 2000, pp. 1325-1335
14. Murphy, SW; Foley, RN; Barrett, BJ; Kent, GM; Morgan, J; Barre, P; Campbell, P; Fine, A; Goldstein, MB; Handa, SP; Jindal, KK; Levin, A; Mandin, H; Muirhead, N; Richardson, RMA; Parfrey, PS
    Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada
    KIDNEY INTERNATIONAL
    
    S.W. Murphy et al., "Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada", KIDNEY INT, 57(6), 2000, pp. 2557-2563
15. Murphy, SW; Foley, RN; Barrett, BJ; Kent, GM; Morgan, J; Barre, P; Campbell, P; Fine, A; Goldstein, MB; Handa, SP; Jindal, KK; Levin, A; Mandin, H; Muirhead, N; Richardson, RMA; Parfrey, PS
    Comparative mortality of hemodialysis and peritoneal dialysis in Canada
    KIDNEY INTERNATIONAL
    
    S.W. Murphy et al., "Comparative mortality of hemodialysis and peritoneal dialysis in Canada", KIDNEY INT, 57(4), 2000, pp. 1720-1726
16. Rigatto, C; Foley, RN; Kent, GM; Guttmann, R; Parfrey, PS
    Long-term changes in left ventricular hypertrophy after renal transplantation
    TRANSPLANTATION
    
    C. Rigatto et al., "Long-term changes in left ventricular hypertrophy after renal transplantation", TRANSPLANT, 70(4), 2000, pp. 570-575
17. Culleton, BF; Larson, MG; Parfrey, PS; Kannel, WB; Levy, D
    Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study
    AMERICAN JOURNAL OF MEDICINE
    
    B.F. Culleton et al., "Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study", AM J MED, 109(1), 2000, pp. 1-8
18. Murphy, ST; Parfrey, PS
    Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    
    S.T. Murphy e P.S. Parfrey, "Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit", CURR OP NEP, 8(5), 1999, pp. 573-578
19. Parfrey, PS; Foley, RN
    The clinical epidemiology of cardiac disease in chronic renal failure
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    P.S. Parfrey e R.N. Foley, "The clinical epidemiology of cardiac disease in chronic renal failure", J AM S NEPH, 10(7), 1999, pp. 1606-1615
20. Parfrey, PS
    Cardiac disease in dialysis patients - Introduction
    SEMINARS IN DIALYSIS
    
    P.S. Parfrey, "Cardiac disease in dialysis patients - Introduction", SEMIN DIAL, 12(2), 1999, pp. 61-61
21. Parfrey, PS
    Pathogenesis of cardiac disease in dialysis patients
    SEMINARS IN DIALYSIS
    
    P.S. Parfrey, "Pathogenesis of cardiac disease in dialysis patients", SEMIN DIAL, 12(2), 1999, pp. 62-68
22. Foley, RN; Parfrey, PS
    Anemia as a risk factor for cardiac disease in dialysis patients
    SEMINARS IN DIALYSIS
    
    R.N. Foley e P.S. Parfrey, "Anemia as a risk factor for cardiac disease in dialysis patients", SEMIN DIAL, 12(2), 1999, pp. 84-86
23. Woods, MO; Young, TL; Parfrey, PS; Hefferton, D; Green, JS; Davidson, WS
    Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: Evidence for a fifth locus
    GENOMICS
    
    M.O. Woods et al., "Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: Evidence for a fifth locus", GENOMICS, 55(1), 1999, pp. 2-9
24. Culleton, BF; Larson, MG; Wilson, PWF; Evans, JC; Parfrey, PS; Levy, D
    Cardiovascular disease and mortality in a community-based cohort with mildrenal insufficiency
    KIDNEY INTERNATIONAL
    
    B.F. Culleton et al., "Cardiovascular disease and mortality in a community-based cohort with mildrenal insufficiency", KIDNEY INT, 56(6), 1999, pp. 2214-2219
25. Parfrey, PS; Foley, RN; Rigatto, C
    Risk issues in renal transplantation: Cardiac aspects
    TRANSPLANTATION PROCEEDINGS
    
    P.S. Parfrey et al., "Risk issues in renal transplantation: Cardiac aspects", TRANSPLAN P, 31(1-2), 1999, pp. 291-293
26. Culleton, BF; Larson, MG; Evans, JC; Wilson, PWF; Barrett, BJ; Parfrey, PS; Levy, D
    Prevalence and correlates of elevated serum creatinine levels - The Framingham heart study
    ARCHIVES OF INTERNAL MEDICINE
    
    B.F. Culleton et al., "Prevalence and correlates of elevated serum creatinine levels - The Framingham heart study", ARCH IN MED, 159(15), 1999, pp. 1785-1790
27. Young, TL; Woods, MO; Parfrey, PS; Green, JS; Hefferton, D; Davidson, WS
    A founder effect in the Newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM
    AMERICAN JOURNAL OF HUMAN GENETICS
    
    T.L. Young et al., "A founder effect in the Newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM", AM J HU GEN, 65(6), 1999, pp. 1680-1687
28. Young, TL; Penney, L; Woods, MO; Parfrey, PS; Green, JS; Hefferton, D; Davidson, WS
    A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31
    AMERICAN JOURNAL OF HUMAN GENETICS
    
    T.L. Young et al., "A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31", AM J HU GEN, 64(3), 1999, pp. 900-904
29. FOLEY RN; PARFREY PS
    CARDIOVASCULAR-DISEASE AND MORTALITY IN ESRD
    JN. Journal of nephrology
    
    R.N. Foley e P.S. Parfrey, "CARDIOVASCULAR-DISEASE AND MORTALITY IN ESRD", JN. Journal of nephrology, 11(5), 1998, pp. 239-245
30. GREGORY DM; WAY CY; HUTCHINSON TA; BARRETT BJ; PARFREY PS
    PATIENTS PERCEPTIONS OF THEIR EXPERIENCES WITH ESRD AND HEMODIALYSIS-TREATMENT
    Qualitative health research
    
    D.M. Gregory et al., "PATIENTS PERCEPTIONS OF THEIR EXPERIENCES WITH ESRD AND HEMODIALYSIS-TREATMENT", Qualitative health research, 8(6), 1998, pp. 764-783
31. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; ODEA R; MURRAY DC; BARRE PE
    MODE OF DIALYSIS THERAPY AND MORTALITY IN END-STAGE RENAL-DISEASE
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "MODE OF DIALYSIS THERAPY AND MORTALITY IN END-STAGE RENAL-DISEASE", Journal of the American Society of Nephrology, 9(2), 1998, pp. 267-276
32. FOLEY RN; PARFREY PS
    CARDIAC DISEASE IN THE DIABETIC DIALYSIS PATIENT
    Nephrology, dialysis, transplantation
    
    R.N. Foley e P.S. Parfrey, "CARDIAC DISEASE IN THE DIABETIC DIALYSIS PATIENT", Nephrology, dialysis, transplantation, 13(5), 1998, pp. 1112-1113
33. FOX GA; ODEA J; PARFREY PS
    CORONARY-ARTERY BYPASS GRAFT-SURGERY IN NEWFOUNDLAND AND LABRADOR
    CMAJ. Canadian Medical Association journal
    
    G.A. Fox et al., "CORONARY-ARTERY BYPASS GRAFT-SURGERY IN NEWFOUNDLAND AND LABRADOR", CMAJ. Canadian Medical Association journal, 158(9), 1998, pp. 1137-1142
34. FOLEY RN; PARFREY PS; SARNAK MJ
    CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE
    American journal of kidney diseases
    
    R.N. Foley et al., "CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE", American journal of kidney diseases, 32(5), 1998, pp. 112-119
35. MURPHY SW; FOLEY RN; PARFREY PS
    SCREENING AND TREATMENT FOR CARDIOVASCULAR-DISEASE IN PATIENTS WITH CHRONIC RENAL-DISEASE
    American journal of kidney diseases
    
    S.W. Murphy et al., "SCREENING AND TREATMENT FOR CARDIOVASCULAR-DISEASE IN PATIENTS WITH CHRONIC RENAL-DISEASE", American journal of kidney diseases, 32(5), 1998, pp. 184-199
36. ODEA DF; MURPHY SW; HEFFERTON D; PARFREY PS
    HIGHER RISK FOR RENAL-FAILURE IN FIRST-DEGREE RELATIVES OF WHITE PATIENTS WITH END-STAGE RENAL-DISEASE - A POPULATION-BASED STUDY
    American journal of kidney diseases
    
    D.F. Odea et al., "HIGHER RISK FOR RENAL-FAILURE IN FIRST-DEGREE RELATIVES OF WHITE PATIENTS WITH END-STAGE RENAL-DISEASE - A POPULATION-BASED STUDY", American journal of kidney diseases, 32(5), 1998, pp. 794-801
37. LEVEY AS; BETO JA; CORONADO BE; EKNOYAN G; FOLEY RN; KASISKE BL; KLAG MJ; MAILLOUX LU; MANSKE CL; MEYER KB; PARFREY PS; PFEFFER MA; WENGER NK; WILSON PWF; WRIGHT JT
    CONTROLLING THE EPIDEMIC OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE - WHAT DO WE KNOW - WHAT DO WE NEED TO LEARN - WHERE DO WE GO FROM HERE
    American journal of kidney diseases
    
    A.S. Levey et al., "CONTROLLING THE EPIDEMIC OF CARDIOVASCULAR-DISEASE IN CHRONIC RENAL-DISEASE - WHAT DO WE KNOW - WHAT DO WE NEED TO LEARN - WHERE DO WE GO FROM HERE", American journal of kidney diseases, 32(5), 1998, pp. 853-906
38. YOUNG TL; WOODS MO; PARFREY PS; GREEN JS; OLEARY E; HEFFERTON D; DAVIDSON WS
    CANADIAN BARDET-BIEDL-SYNDROME FAMILY REDUCES THE CRITICAL REGION OF BBS3 (3P) AND PRESENTS WITH A VARIABLE PHENOTYPE
    American journal of medical genetics
    
    T.L. Young et al., "CANADIAN BARDET-BIEDL-SYNDROME FAMILY REDUCES THE CRITICAL REGION OF BBS3 (3P) AND PRESENTS WITH A VARIABLE PHENOTYPE", American journal of medical genetics, 78(5), 1998, pp. 461-467
39. FOLEY RN; PARFREY PS; KENT GM; HARNETT JD; MURRAY DC; BARRE PE
    LONG-TERM EVOLUTION OF CARDIOMYOPATHY IN DIALYSIS PATIENTS
    Kidney international
    
    R.N. Foley et al., "LONG-TERM EVOLUTION OF CARDIOMYOPATHY IN DIALYSIS PATIENTS", Kidney international, 54(5), 1998, pp. 1720-1725
40. BARRETT BJ; PARFREY PS; MORTON BC
    SAFETY AND CRITERIA FOR SELECTIVE USE OF LOW-OSMOLALITY CONTRAST FOR CARDIAC ANGIOGRAPHY
    Medical care
    
    B.J. Barrett et al., "SAFETY AND CRITERIA FOR SELECTIVE USE OF LOW-OSMOLALITY CONTRAST FOR CARDIAC ANGIOGRAPHY", Medical care, 36(8), 1998, pp. 1189-1197
41. CULLETON BF; LARSON MG; BARRETT BJ; PARFREY PS; LEVY D
    PREDICTORS OF AN ELEVATED SERUM CREATININE - THE FRAMINGHAM HEART-STUDY
    Journal of the American Society of Nephrology
    
    B.F. Culleton et al., "PREDICTORS OF AN ELEVATED SERUM CREATININE - THE FRAMINGHAM HEART-STUDY", Journal of the American Society of Nephrology, 8, 1997, pp. 644-644
42. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    MORTALITY IN ESRD - THE RESCUE EFFECT OF SWITCHING FROM PD TO HEMODIALYSIS
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "MORTALITY IN ESRD - THE RESCUE EFFECT OF SWITCHING FROM PD TO HEMODIALYSIS", Journal of the American Society of Nephrology, 8, 1997, pp. 1007-1007
43. FOLEY RN; PARFREY PS; KENT GM
    EARLY AND LATE MORTALITY IN ESRD - HAZARDS OF THE COX MODEL
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "EARLY AND LATE MORTALITY IN ESRD - HAZARDS OF THE COX MODEL", Journal of the American Society of Nephrology, 8, 1997, pp. 1303-1303
44. YOUNG TL; WOODS MO; PARFREY PS; HEFFERTON D; GREEN JS; DAVIDSON WS
    GENETIC-HETEROGENEITY IN 16 NEWFOUNDLAND FAMILIES WITH BARDET-BIEDL-SYNDROME
    Journal of the American Society of Nephrology
    
    T.L. Young et al., "GENETIC-HETEROGENEITY IN 16 NEWFOUNDLAND FAMILIES WITH BARDET-BIEDL-SYNDROME", Journal of the American Society of Nephrology, 8, 1997, pp. 1838-1838
45. FOLEY RN; PARFREY PS
    COMMENTARY - CARDIOMYOPATHY OF ANEMIA AND THE POTENTIAL OF ERYTHROPOIETIN
    Peritoneal dialysis international
    
    R.N. Foley e P.S. Parfrey, "COMMENTARY - CARDIOMYOPATHY OF ANEMIA AND THE POTENTIAL OF ERYTHROPOIETIN", Peritoneal dialysis international, 17(2), 1997, pp. 117-118
46. PARFREY PS; FOLEY RN
    RISK-FACTORS FOR CARDIAC DYSFUNCTION IN DIALYSIS PATIENTS - IMPLICATIONS FOR PATIENT-CARE
    Seminars in dialysis
    
    P.S. Parfrey e R.N. Foley, "RISK-FACTORS FOR CARDIAC DYSFUNCTION IN DIALYSIS PATIENTS - IMPLICATIONS FOR PATIENT-CARE", Seminars in dialysis, 10(3), 1997, pp. 137-141
47. BARRETT BJ; PARFREY PS; MORGAN J; BARRE P; FINE A; GOLDSTEIN MB; HANDA SP; JINDAL KK; KJELLSTRAND CM; LEVIN A; MANDIN H; MUIRHEAD N; RICHARDSON RMA
    PREDICTION OF EARLY DEATH IN END-STAGE RENAL-DISEASE PATIENTS STARTING DIALYSIS
    American journal of kidney diseases
    
    B.J. Barrett et al., "PREDICTION OF EARLY DEATH IN END-STAGE RENAL-DISEASE PATIENTS STARTING DIALYSIS", American journal of kidney diseases, 29(2), 1997, pp. 214-222
48. FOLEY RN; CULLETON BF; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    CARDIAC DISEASE IN DIABETIC END-STAGE RENAL-DISEASE
    Diabetologia
    
    R.N. Foley et al., "CARDIAC DISEASE IN DIABETIC END-STAGE RENAL-DISEASE", Diabetologia, 40(11), 1997, pp. 1307-1312
49. DAVIDSON WS; JONES GJ; PARFREY PS; HEFFERTON D; GREEN JS; GUAYWOODFORD LM; YOUNG TL
    A NEWFOUNDLAND FAMILY NARROWS THE AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY-DISEASE (ARPKD) CRITICAL REGION ON 6P
    American journal of human genetics
    
    W.S. Davidson et al., "A NEWFOUNDLAND FAMILY NARROWS THE AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY-DISEASE (ARPKD) CRITICAL REGION ON 6P", American journal of human genetics, 61(4), 1997, pp. 1585-1585
50. YOUNG TL; WOODS MO; PARFREY PS; HEFFERTON D; GREEN JS; DAVIDSON WS
    HOMOZYGOSITY MAPPING IN A CONSANGUINEOUS NEWFOUNDLAND KINDRED NARROWSTHE CRITICAL REGION OF BARDET-BIELD-SYNDROME ON 11Q (BBS1)
    American journal of human genetics
    
    T.L. Young et al., "HOMOZYGOSITY MAPPING IN A CONSANGUINEOUS NEWFOUNDLAND KINDRED NARROWSTHE CRITICAL REGION OF BARDET-BIELD-SYNDROME ON 11Q (BBS1)", American journal of human genetics, 61(4), 1997, pp. 1762-1762
51. CULLETON BF; FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    CARDIAC DISEASE IN DIABETIC-PATIENTS WITH ESRD
    Journal of the American Society of Nephrology
    
    B.F. Culleton et al., "CARDIAC DISEASE IN DIABETIC-PATIENTS WITH ESRD", Journal of the American Society of Nephrology, 7(9), 1996, pp. 977-977
52. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    MODE OF DIALYSIS, CARDIAC MORBIDITY AND MORTALITY IN ESRD
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "MODE OF DIALYSIS, CARDIAC MORBIDITY AND MORTALITY IN ESRD", Journal of the American Society of Nephrology, 7(9), 1996, pp. 993-993
53. ODEA DF; HARNETT J; HEFFERTON D; PARFREY PS
    FAMILIAL RISK OF END-STAGE RENAL-DISEASE IN A CAUCASIAN POPULATION
    Journal of the American Society of Nephrology
    
    D.F. Odea et al., "FAMILIAL RISK OF END-STAGE RENAL-DISEASE IN A CAUCASIAN POPULATION", Journal of the American Society of Nephrology, 7(9), 1996, pp. 1849-1849
54. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    HYPOALBUMINEMIA, CARDIAC MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "HYPOALBUMINEMIA, CARDIAC MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE", Journal of the American Society of Nephrology, 7(5), 1996, pp. 728-736
55. PARFREY PS; FOLEY RN; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    OUTCOME AND RISK-FACTORS FOR LEFT-VENTRICULAR DISORDERS IN CHRONIC UREMIA
    Nephrology, dialysis, transplantation
    
    P.S. Parfrey et al., "OUTCOME AND RISK-FACTORS FOR LEFT-VENTRICULAR DISORDERS IN CHRONIC UREMIA", Nephrology, dialysis, transplantation, 11(7), 1996, pp. 1277-1285
56. PARFREY PS; COLLINGWOOD P; FOLEY RN; BAHRLE A
    LEFT-VENTRICULAR DISORDERS DETECTED BY M-MODE ECHOCARDIOGRAPHY IN CHRONIC UREMIA
    Nephrology, dialysis, transplantation
    
    P.S. Parfrey et al., "LEFT-VENTRICULAR DISORDERS DETECTED BY M-MODE ECHOCARDIOGRAPHY IN CHRONIC UREMIA", Nephrology, dialysis, transplantation, 11(7), 1996, pp. 1328-1331
57. CULLETON B; PARFREY PS
    CARDIOVASCULAR RISK IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS
    Peritoneal dialysis international
    
    B. Culleton e P.S. Parfrey, "CARDIOVASCULAR RISK IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS", Peritoneal dialysis international, 16(1), 1996, pp. 10-12
58. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    THE IMPACT OF ANEMIA ON CARDIOMYOPATHY, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE
    American journal of kidney diseases
    
    R.N. Foley et al., "THE IMPACT OF ANEMIA ON CARDIOMYOPATHY, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE", American journal of kidney diseases, 28(1), 1996, pp. 53-61
59. PARFREY PS; FOLEY RN
    ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA
    Blood purification
    
    P.S. Parfrey e R.N. Foley, "ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA", Blood purification, 14(4), 1996, pp. 321-326
60. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; HU LQ; ODEA R; MURRAY DC; BARRE PE
    HYPOCALCEMIA, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE
    American journal of nephrology
    
    R.N. Foley et al., "HYPOCALCEMIA, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE", American journal of nephrology, 16(5), 1996, pp. 386-393
61. BUTLER JS; BARRETT BJ; KENT G; MCDONALD J; HAIRE R; PARFREY PS
    DETECTION AND CLASSIFICATION OF INAPPROPRIATE HOSPITAL STAY
    Clinical and investigative medicine
    
    J.S. Butler et al., "DETECTION AND CLASSIFICATION OF INAPPROPRIATE HOSPITAL STAY", Clinical and investigative medicine, 19(4), 1996, pp. 251-258
62. BARRETT BJ; PARFREY PS; MCDONALD J; HAIRE R; PEACHEY G
    CONCURRENT UTILIZATION REVIEW AND INAPPROPRIATE HOSPITAL STAY - EVALUATION OF A PROGRAM
    Clinical and investigative medicine
    
    B.J. Barrett et al., "CONCURRENT UTILIZATION REVIEW AND INAPPROPRIATE HOSPITAL STAY - EVALUATION OF A PROGRAM", Clinical and investigative medicine, 19(1), 1996, pp. 28-35
63. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    IMPACT OF HYPERTENSION ON CARDIOMYOPATHY, MORBIDITY AND MORTALITY IN END-STAGE RENAL-DISEASE
    Kidney international
    
    R.N. Foley et al., "IMPACT OF HYPERTENSION ON CARDIOMYOPATHY, MORBIDITY AND MORTALITY IN END-STAGE RENAL-DISEASE", Kidney international, 49(5), 1996, pp. 1379-1385
64. PARFREY PS; FOLEY RN; HARNETT JD; KENT GM; MURRAY D; BARRE PE
    OUTCOME AND RISK-FACTORS OF ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA
    Kidney international
    
    P.S. Parfrey et al., "OUTCOME AND RISK-FACTORS OF ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA", Kidney international, 49(5), 1996, pp. 1428-1434
65. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    HYPERTENSION, CARDIOMYOPATHY, CARDIAC MORBIDITY AND MORTALITY IN ESRD
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "HYPERTENSION, CARDIOMYOPATHY, CARDIAC MORBIDITY AND MORTALITY IN ESRD", Journal of the American Society of Nephrology, 6(3), 1995, pp. 529-529
66. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    HYPOALBUMINEMIA - A MAJOR RISK FACTOR FOR CARDIAC DISEASE IN ESRD
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "HYPOALBUMINEMIA - A MAJOR RISK FACTOR FOR CARDIAC DISEASE IN ESRD", Journal of the American Society of Nephrology, 6(3), 1995, pp. 529-529
67. PARFREY PS; HARNETT JD; KENT GM; ODEA R; MURRAY D; BARRE PE
    THE NATURAL-HISTORY OF UREMIC CARDIOMYOPATHY
    Journal of the American Society of Nephrology
    
    P.S. Parfrey et al., "THE NATURAL-HISTORY OF UREMIC CARDIOMYOPATHY", Journal of the American Society of Nephrology, 6(3), 1995, pp. 555-555
68. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    THE PROGNOSTIC IMPORTANCE OF LEFT-VENTRICULAR GEOMETRY IN UREMIC CARDIOMYOPATHY
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "THE PROGNOSTIC IMPORTANCE OF LEFT-VENTRICULAR GEOMETRY IN UREMIC CARDIOMYOPATHY", Journal of the American Society of Nephrology, 5(12), 1995, pp. 2024-2031
69. HARNETT JD; KENT GM; FOLEY RN; PARFREY PS
    CARDIAC-FUNCTION AND HEMATOCRIT LEVEL
    American journal of kidney diseases
    
    J.D. Harnett et al., "CARDIAC-FUNCTION AND HEMATOCRIT LEVEL", American journal of kidney diseases, 25(4), 1995, pp. 3-7
70. HARNETT JD; FOLEY RN; KENT GM; BARRE PE; MURRAY D; PARFREY PS
    CONGESTIVE-HEART-FAILURE IN DIALYSIS PATIENTS - PREVALENCE, INCIDENCE, PROGNOSIS AND RISK-FACTORS
    Kidney international
    
    J.D. Harnett et al., "CONGESTIVE-HEART-FAILURE IN DIALYSIS PATIENTS - PREVALENCE, INCIDENCE, PROGNOSIS AND RISK-FACTORS", Kidney international, 47(3), 1995, pp. 884-890
71. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MARTIN CJ; MURRAY DC; BARRE PE
    CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGERENAL-DISEASE THERAPY
    Kidney international
    
    R.N. Foley et al., "CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGERENAL-DISEASE THERAPY", Kidney international, 47(1), 1995, pp. 186-192
72. PARFREY PS; HARNETT JD; FOLEY RN; KENT GM; MURRAY DC; BARRE PE; GUTTMANN RD
    IMPACT OF RENAL-TRANSPLANTATION ON UREMIC CARDIOMYOPATHY
    Transplantation
    
    P.S. Parfrey et al., "IMPACT OF RENAL-TRANSPLANTATION ON UREMIC CARDIOMYOPATHY", Transplantation, 60(9), 1995, pp. 908-914
73. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; HU LQ; MURRAY DC; BARRE PE
    CHRONIC HYPOCALCEMIA - A MAJOR MORBIDITY AND MORTALITY FACTOR IN ESRDPATIENTS
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "CHRONIC HYPOCALCEMIA - A MAJOR MORBIDITY AND MORTALITY FACTOR IN ESRDPATIENTS", Journal of the American Society of Nephrology, 5(3), 1994, pp. 446-446
74. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    LEFT-VENTRICULAR (LV) GEOMETRY - A CRITICAL PROGNOSTIC VARIABLE IN ESRD PATIENTS
    Journal of the American Society of Nephrology
    
    R.N. Foley et al., "LEFT-VENTRICULAR (LV) GEOMETRY - A CRITICAL PROGNOSTIC VARIABLE IN ESRD PATIENTS", Journal of the American Society of Nephrology, 5(3), 1994, pp. 446-446
75. HARNETT JD; PARFREY PS; FOLEY RN; KENT GM; HU LQ; ODEA R; MURRAY DC; BARRE PE
    ISCHEMIC-HEART-DISEASE IN ESRD - PREVALENCE, PROGNOSIS AND RISK-FACTORS
    Journal of the American Society of Nephrology
    
    J.D. Harnett et al., "ISCHEMIC-HEART-DISEASE IN ESRD - PREVALENCE, PROGNOSIS AND RISK-FACTORS", Journal of the American Society of Nephrology, 5(3), 1994, pp. 452-452
76. HARNETT JD; FOLEY RN; PARFREY PS; KENT GM; MURRAY D; BARRE PE
    THE EFFECT OF RENAL-TRANSPLANTATION ON CARDIAC-FUNCTION IN DIALYSIS PATIENTS
    Journal of the American Society of Nephrology
    
    J.D. Harnett et al., "THE EFFECT OF RENAL-TRANSPLANTATION ON CARDIAC-FUNCTION IN DIALYSIS PATIENTS", Journal of the American Society of Nephrology, 5(3), 1994, pp. 1010-1010
77. HARNETT JD; KENT GM; BARRE PE; TAYLOR R; PARFREY PS
    RISK-FACTORS FOR THE DEVELOPMENT OF LEFT-VENTRICULAR HYPERTROPHY IN APROSPECTIVELY FOLLOWED COHORT OF DIALYSIS PATIENTS
    Journal of the American Society of Nephrology
    
    J.D. Harnett et al., "RISK-FACTORS FOR THE DEVELOPMENT OF LEFT-VENTRICULAR HYPERTROPHY IN APROSPECTIVELY FOLLOWED COHORT OF DIALYSIS PATIENTS", Journal of the American Society of Nephrology, 4(7), 1994, pp. 1486-1490
78. BARRETT BJ; PARFREY PS; FOLEY RN; DETSKY AS
    AN ECONOMIC-ANALYSIS OF STRATEGIES FOR THE USE OF CONTRAST-MEDIA FOR DIAGNOSTIC CARDIAC-CATHETERIZATION
    Medical decision making
    
    B.J. Barrett et al., "AN ECONOMIC-ANALYSIS OF STRATEGIES FOR THE USE OF CONTRAST-MEDIA FOR DIAGNOSTIC CARDIAC-CATHETERIZATION", Medical decision making, 14(4), 1994, pp. 325-335
79. FOLEY RN; PARFREY PS; HEFFERTON D; SINGH I; SIMMS A; BARRETT BJ
    ADVANCE PREDICTION OF EARLY DEATH IN PATIENTS STARTING MAINTENANCE DIALYSIS
    American journal of kidney diseases
    
    R.N. Foley et al., "ADVANCE PREDICTION OF EARLY DEATH IN PATIENTS STARTING MAINTENANCE DIALYSIS", American journal of kidney diseases, 23(6), 1994, pp. 836-845
80. HARNETT JD; PARFREY PS
    CARDIAC DISEASE IN UREMIA
    Seminars in nephrology
    
    J.D. Harnett e P.S. Parfrey, "CARDIAC DISEASE IN UREMIA", Seminars in nephrology, 14(3), 1994, pp. 245-252
81. PARFREY PS; HARNETT JD
    CLINICAL ASPECTS OF CARDIOMYOPATHY IN DIALYSIS PATIENTS
    Blood purification
    
    P.S. Parfrey e J.D. Harnett, "CLINICAL ASPECTS OF CARDIOMYOPATHY IN DIALYSIS PATIENTS", Blood purification, 12(4-5), 1994, pp. 267-276
82. PARFREY PS
    CLINICAL EPIDEMIOLOGY IN CHRONIC UREMIA
    Clinical and investigative medicine
    
    P.S. Parfrey, "CLINICAL EPIDEMIOLOGY IN CHRONIC UREMIA", Clinical and investigative medicine, 17(5), 1994, pp. 466-473
83. PARFREY PS; GARDNER E; VAVASOUR H; HARNETT JD; MCMANAMON C; MCDONALD J; DAWE J
    THE FEASIBILITY AND EFFICACY OF EARLY DISCHARGE PLANNING INITIATED BYTHE ADMITTING DEPARTMENT IN 2 ACUTE-CARE HOSPITALS
    Clinical and investigative medicine
    
    P.S. Parfrey et al., "THE FEASIBILITY AND EFFICACY OF EARLY DISCHARGE PLANNING INITIATED BYTHE ADMITTING DEPARTMENT IN 2 ACUTE-CARE HOSPITALS", Clinical and investigative medicine, 17(2), 1994, pp. 88-96
84. BARRETT BJ; PARFREY PS
    PREVENTION OF NEPHROTOXICITY INDUCED BY RADIOCONTRAST AGENTS
    The New England journal of medicine
    
    B.J. Barrett e P.S. Parfrey, "PREVENTION OF NEPHROTOXICITY INDUCED BY RADIOCONTRAST AGENTS", The New England journal of medicine, 331(21), 1994, pp. 1449-1450
85. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    LEFT-VENTRICULAR (LV) GEOMETRY - A CRITICAL PROGNOSTIC VARIABLE IN ESRD PATIENTS
    Clinical research
    
    R.N. Foley et al., "LEFT-VENTRICULAR (LV) GEOMETRY - A CRITICAL PROGNOSTIC VARIABLE IN ESRD PATIENTS", Clinical research, 42(2), 1994, pp. 10000223-10000223
86. HARNETT JD; PARFREY PS; KENT GM; FOLEY RN; BARRE PE
    CONGESTIVE-HEART-FAILURE (CHF) IN DIALYSIS PATIENTS - PREVALENCE, INCIDENCE, RISK-FACTORS AND PROGNOSIS
    Clinical research
    
    J.D. Harnett et al., "CONGESTIVE-HEART-FAILURE (CHF) IN DIALYSIS PATIENTS - PREVALENCE, INCIDENCE, RISK-FACTORS AND PROGNOSIS", Clinical research, 42(2), 1994, pp. 10000262-10000262
87. FOLEY RN; PARFREY PS; HARNETT JD; KENT GM; MURRAY DC; BARRE PE
    ANEMIA AND RELATIVE HYPOTENSION ARE IMPORTANT RISK-FACTORS FOR DEATH IN DIALYSIS PATIENTS
    Clinical research
    
    R.N. Foley et al., "ANEMIA AND RELATIVE HYPOTENSION ARE IMPORTANT RISK-FACTORS FOR DEATH IN DIALYSIS PATIENTS", Clinical research, 42(2), 1994, pp. 10000264-10000264
88. HARNETT JD; MURPHY B; COLLINGWOOD P; PURCHASE L; KENT G; PARFREY PS
    THE RELIABILITY AND VALIDITY OF ECHOCARDIOGRAPHIC MEASUREMENT OF LEFT-VENTRICULAR MASS INDEX IN HEMODIALYSIS-PATIENTS
    Nephron
    
    J.D. Harnett et al., "THE RELIABILITY AND VALIDITY OF ECHOCARDIOGRAPHIC MEASUREMENT OF LEFT-VENTRICULAR MASS INDEX IN HEMODIALYSIS-PATIENTS", Nephron, 65(2), 1993, pp. 212-214